Searched for
PHARMA STOCKS
Cipla Q1 Results: Cons profit drops 39% YoY to Rs 789 crore; revenue rises marginallyCipla Q1 Results: Pharma major Cipla reported a 39% year-on-year decline in Q1FY27 consolidated net profit to Rs 789 crore, mainly due to a...- Oil at $90-100 will impact macros and the market: Sunil Koul, Goldman SachsGlobal investors show increased interest in India's equity markets recently. Corporate earnings and economic performance have remained quit...
- Emami among 4 stocks closed above VWAP, signalling bullish shiftOn July 22, four stocks in the Nifty500 pack rallied more than 1% above their Volume Weighted Average Price (VWAP), according to StockEdge'...
- Benchmark indices fall amid rising crude oil prices and West Asia conflictIndia's benchmark indices ended lower on Wednesday, as crude oil prices increased. The Nifty50 and Sensex experienced significant drops, fa...
- Pharma stocks slide as Trump's 100% generic drug tariff plan spooks investorsIndian drug shares declined Wednesday following US President Trump's tariff announcement. These proposed tariffs will significantly impact ...
- Why did market fall today? 7 triggers behind Rs 4 lakh crore wealth wipeoutIndian stock markets experienced significant declines on Wednesday. Escalating Iran-US tensions and tariff threats spooked investors, causi...
- Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investorsDonald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analys...
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...
- Two Trades for Today: A mid-cap pharma stock for a 8.69% upmove, a South India-focused private bank for a 7% gainOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...
- MedPlus Health shares tumble 16% after Q1 profit falls 21% YoY. Should you buy, sell or hold?MedPlus Health Services shares tumbled after the company reported a weaker-than-expected Q1FY27. Despite healthy 21.9% revenue growth to ₹1...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian markets extended losses as large-cap weakness outweighed gains in broader indices despite easing oil prices. Analysts expect earning...
- MSCI India rejig: Eternal likely to see highest inflows at $648 mn; Lenskart, Groww among Nuvama’s expected inclusionsMSCI’s August India Standard Index review could trigger major passive inflows, with Eternal expected to attract the highest at $648 million...
- Stocks in news: CDSL, Adani Energy, L&T, Adani Total Gas, Emcure PharmaMarkets declined on Monday due to disappointing earnings and geopolitical worries. CDSL faced a Rs 1 crore penalty from Sebi for cybersecur...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian markets ended lower as escalating Iran-US tensions and rising crude prices weighed on sentiment. Analysts expect geopolitical risks,...
- Natco Pharma shares surge 5% after US FDA's tentative nod Olaparib tabletsNatco Pharma shares rose sharply on Monday after the U.S. FDA granted tentative approval for its generic Olaparib tablets, a bioequivalent ...
- Quant Mid Cap Fund exits Reliance Industries and 3 others, adds BHEL, 1 other stock in JuneQuant Mid Cap Fund exited Reliance Industries and three other stocks in June while adding BHEL and L&T Technology Services to its portfolio...
- Reliance Industries, Groww and MTAR Technologies among stocks bought and sold by mutual funds in JuneMutual funds invested Rs 50,600 crore in stocks during June. They significantly bought JSWInfra, Bajaj Finance, and HDFC Bank. Conversely, ...
- Bonus issue alert! Last day to buy this microcap pharma stock that rallied 200% in one yearFredun Pharmaceuticals has fixed July 16 as the record date for its 2:1 bonus issue, making today the last day to buy the stock to qualify....
Load More
